Literature DB >> 10528136

Troglitazone but not pioglitazone affects ATP-sensitive K(+) channel activity.

Y Sunaga1, N Inagaki, T Gonoi, Y Yamada, H Ishida, Y Seino, S Seino.   

Abstract

We compared the effects of the two thiazolidinedione derivatives, troglitazone and pioglitazone, on ATP-sensitive K(+) (K(ATP)) channel activities. Pancreatic beta-cell type and cardiac type K(ATP) channels were reconstituted in COS-1 cells (SV 40-transformed African green monkey kidney (AGMK) cells) by heterologously expressing sulfonylurea receptor 1 (SUR1) plus Kir6.2 and sulfonylurea receptor 2A (SUR2A) plus Kir6.2, respectively. Troglitazone inhibited [86Rb(+)] efflux in both K(ATP) channel types in the presence of metabolic inhibitors, which was confirmed by electrophysiological techniques. The [86Rb(+)] efflux increased by the channel openers diazoxide and pinacidil was abolished by troglitazone. In contrast, pioglitazone did not affect these channel activities in either type K(ATP) channel. These results suggest that troglitazone modulates the various cellular functions including insulin secretion by inhibiting the K(ATP) channels, while pioglitazone has no effect on K(ATP) channel activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528136     DOI: 10.1016/s0014-2999(99)00539-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty.

Authors:  Janice V Huang; Clifford R Greyson; Gregory G Schwartz
Journal:  J Lipid Res       Date:  2012-06-08       Impact factor: 5.922

2.  Thiazolidinedione drugs promote onset, alter characteristics, and increase mortality of ischemic ventricular fibrillation in pigs.

Authors:  Mohammad Sarraf; Li Lu; Shuyu Ye; Michael J Reiter; Clifford R Greyson; Gregory G Schwartz
Journal:  Cardiovasc Drugs Ther       Date:  2012-06       Impact factor: 3.727

3.  Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs.

Authors:  Ya Xu; Li Lu; Clifford Greyson; Jenny Lee; Michael Gen; Koichiro Kinugawa; Carlin S Long; Gregory G Schwartz
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

4.  Thiazolidinedione drugs block cardiac KATP channels and may increase propensity for ischaemic ventricular fibrillation in pigs.

Authors:  L Lu; M J Reiter; Y Xu; A Chicco; C R Greyson; G G Schwartz
Journal:  Diabetologia       Date:  2008-02-05       Impact factor: 10.122

5.  Pioglitazone, a PPAR-γ Activator, Stimulates BKCa but Suppresses IK M in Hippocampal Neurons.

Authors:  Tsang-Shan Chen; Ming-Chi Lai; Te-Yu Hung; Kao-Min Lin; Chin-Wei Huang; Sheng-Nan Wu
Journal:  Front Pharmacol       Date:  2018-08-29       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.